These investigators suggested that hyperglycemia mediates the production of superoxide as well as the glycolytic metabolite; methylglyoxal responsible for modification of the co-activator p300 and hence decreases its association with HIF-1α, resulting in impaired HIF-1α- mediated VEGF gene transactivation and poor vascularization. The gene discussed is EP300; the disease is Hyperglycemia.